Loading the section
Closing prices for September 17, 2026
The series is stated in the current share scale after splits; dividends are not included in the price
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| September 17, 2026 | 50.72 | 51.08 | 50.62 | 51.06 | 3m |
| September 16, 2026 | 50.19 | 50.71 | 50.06 | 50.29 | 3m |
| September 15, 2026 | 49.69 | 50.16 | 49.63 | 50.01 | 3m |
| September 14, 2026 | 50.29 | 50.30 |
Based on reports through December 31, 2025
GSK plc (GSK) is a public company in the healthcare sector. Its depositary receipts trade on NYSE.
Over the trailing twelve months as reported to 2025-12-31, revenue was 32.7bn £, net income was 6.3bn £. Incorporated in GB.
This summary is compiled automatically from SEC filings and exchange data.
Address:79 NEW OXFORD STREET, LONDON, WC1A 1DG
| 83m |
| LEGNLegend Biotech Corporation | 17.64 | +376.80 % | 44m |
| GPCRStructure Therapeutics Inc. | 35.44 | −16.90 % | 42m |
| BLTEBelite Bio, Inc | 169.64 | +25.30 % | 35m |
| ZLABZai Lab Limited | 25.81 | +4.62 % | 31m |
| 49.61 |
| 50.05 |
| 3m |
| September 11, 2026 | 48.70 | 48.80 | 47.85 | 48.13 | 2m |
| September 10, 2026 | 48.47 | 48.59 | 47.98 | 48.12 | 2m |
| September 09, 2026 | 48.82 | 49.16 | 48.60 | 48.63 | 2m |
| September 08, 2026 | 49.00 | 49.23 | 48.54 | 48.54 | 3m |
| September 04, 2026 | 49.70 | 50.06 | 49.66 | 49.89 | 2m |
| September 03, 2026 | 51.50 | 51.52 | 50.19 | 50.87 | 2m |
| September 02, 2026 | 50.36 | 51.08 | 50.04 | 50.44 | 3m |
| September 01, 2026 | 51.11 | 51.26 | 50.47 | 50.66 | 3m |
| August 31, 2026 | 50.62 | 50.82 | 50.25 | 50.25 | 2m |
| August 28, 2026 | 50.22 | 50.88 | 49.95 | 50.82 | 3m |
| August 27, 2026 | 50.95 | 51.03 | 50.17 | 50.27 | 2m |
| August 26, 2026 | 51.90 | 52.09 | 51.40 | 51.43 | 2m |
| August 25, 2026 | 51.57 | 52.21 | 51.51 | 52.07 | 3m |
| August 24, 2026 | 51.54 | 51.95 | 51.40 | 51.78 | 3m |
| August 21, 2026 | 51.35 | 52.57 | 51.35 | 52.41 | 2m |
| August 20, 2026 | 52.57 | 52.63 | 51.86 | 51.96 | 4m |